coreTherapeuticArea
P137286
predicate
Indicates the primary medical or clinical domain in which a therapy, treatment, or product is principally intended to be used.
All labels observed (5)
| Label | Occurrences |
|---|---|
| focusesOnTherapeuticArea | 12 |
| coreTherapeuticArea canonical | 7 |
| primaryTherapeuticArea | 4 |
| clinicalArea | 3 |
| associatedWithTherapeuticArea | 1 |
Description generation (PDg)
The one-sentence description above was generated by prompting gpt-5.1 with the predicate name and this instruction.
Instruction
Given a predicate that represents a relationship or action between entities, generate a one-sentence description explaining its meaning. # Instructions Focus on describing the relationship, not the entities themselves. # Response Format Begin the description with \' Indicates...\'
Input
Predicate: coreTherapeuticArea
Generated description
Indicates the primary medical or clinical domain in which a therapy, treatment, or product is principally intended to be used.
Sample triples (27)
| Subject | Object |
|---|---|
| Takeda Pharmaceutical Company | oncology ⓘ |
| Takeda Pharmaceutical Company | gastroenterology ⓘ |
| Takeda Pharmaceutical Company | neuroscience ⓘ |
| Takeda Pharmaceutical Company | rare diseases ⓘ |
|
AZN
surface form:
AstraZeneca plc
|
oncology via predicate surface "focusesOnTherapeuticArea" ⓘ |
|
AZN
surface form:
AstraZeneca plc
|
cardiovascular via predicate surface "focusesOnTherapeuticArea" ⓘ |
|
AZN
surface form:
AstraZeneca plc
|
renal via predicate surface "focusesOnTherapeuticArea" ⓘ |
|
AZN
surface form:
AstraZeneca plc
|
metabolism via predicate surface "focusesOnTherapeuticArea" ⓘ |
|
AZN
surface form:
AstraZeneca plc
|
respiratory via predicate surface "focusesOnTherapeuticArea" ⓘ |
|
AZN
surface form:
AstraZeneca plc
|
immunology via predicate surface "focusesOnTherapeuticArea" ⓘ |
|
AZN
surface form:
AstraZeneca plc
|
rare diseases via predicate surface "focusesOnTherapeuticArea" ⓘ |
| AZN | oncology via predicate surface "associatedWithTherapeuticArea" ⓘ |
| SIGA Technologies | infectious diseases via predicate surface "primaryTherapeuticArea" ⓘ |
| SIGA Technologies | viral infections via predicate surface "primaryTherapeuticArea" ⓘ |
| Peptamen | gastroenterology via predicate surface "clinicalArea" ⓘ |
| Peptamen | critical care nutrition via predicate surface "clinicalArea" ⓘ |
| Peptamen | surgical nutrition support via predicate surface "clinicalArea" ⓘ |
| Organon | women's health ⓘ |
| Organon | biosimilars ⓘ |
| Organon | established brands ⓘ |
|
NYSE:ELN
surface form:
Elan Corporation plc
|
neurology via predicate surface "primaryTherapeuticArea" ⓘ |
|
NYSE:ELN
surface form:
Elan Corporation plc
|
immunology via predicate surface "primaryTherapeuticArea" ⓘ |
| Bristol Myers Squibb | oncology via predicate surface "focusesOnTherapeuticArea" ⓘ |
| Bristol Myers Squibb | immunology via predicate surface "focusesOnTherapeuticArea" ⓘ |
| Bristol Myers Squibb | cardiovascular disease via predicate surface "focusesOnTherapeuticArea" ⓘ |
| Bristol Myers Squibb | hematology via predicate surface "focusesOnTherapeuticArea" ⓘ |
| Bristol Myers Squibb | fibrosis via predicate surface "focusesOnTherapeuticArea" ⓘ |